These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


153 related items for PubMed ID: 9400029

  • 1. The protective effect of metallothionein against lipid peroxidation caused by retinoic acid in human breast cancer cells.
    Hurnanen D, Chan HM, Kubow S.
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1520-8. PubMed ID: 9400029
    [Abstract] [Full Text] [Related]

  • 2. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
    Gucev ZS, Oh Y, Kelley KM, Rosenfeld RG.
    Cancer Res; 1996 Apr 01; 56(7):1545-50. PubMed ID: 8603400
    [Abstract] [Full Text] [Related]

  • 3. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
    Liu L, Gudas LJ.
    J Cell Physiol; 2002 Nov 01; 193(2):244-52. PubMed ID: 12385002
    [Abstract] [Full Text] [Related]

  • 4. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells.
    Abdel-Mageed A, Agrawal KC.
    Cancer Gene Ther; 1997 Nov 01; 4(3):199-207. PubMed ID: 9171939
    [Abstract] [Full Text] [Related]

  • 5. Metallothionein 1E mRNA is highly expressed in oestrogen receptor-negative human invasive ductal breast cancer.
    Jin R, Bay BH, Chow VT, Tan PH, Lin VC.
    Br J Cancer; 2000 Aug 01; 83(3):319-23. PubMed ID: 10917545
    [Abstract] [Full Text] [Related]

  • 6. Retinoic acid inhibition of insulin-like growth factor I stimulation of c-fos mRNA levels in a breast carcinoma cell line.
    Li XS, Chen JC, Sheikh MS, Shao ZM, Fontana JA.
    Exp Cell Res; 1994 Mar 01; 211(1):68-73. PubMed ID: 8125161
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
    Hayashi K, Goodison S, Urquidi V, Tarin D, Lotan R, Tahara E.
    Int J Oncol; 2003 Mar 01; 22(3):623-9. PubMed ID: 12579317
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of zinc on rat hepatoma HTC cells and primary cultured rat hepatocytes.
    Steinebach OM, Wolterbeek HT.
    Toxicol Appl Pharmacol; 1993 Feb 01; 118(2):245-54. PubMed ID: 8442003
    [Abstract] [Full Text] [Related]

  • 10. Retinoic acid and ascorbic acid act synergistically in inhibiting human breast cancer cell proliferation.
    Kim KN, Pie JE, Park JH, Park YH, Kim HW, Kim MK.
    J Nutr Biochem; 2006 Jul 01; 17(7):454-62. PubMed ID: 16443354
    [Abstract] [Full Text] [Related]

  • 11. ZnT2-overexpression represses the cytotoxic effects of zinc hyper-accumulation in malignant metallothionein-null T47D breast tumor cells.
    Lopez V, Foolad F, Kelleher SL.
    Cancer Lett; 2011 May 01; 304(1):41-51. PubMed ID: 21353385
    [Abstract] [Full Text] [Related]

  • 12. Metallothionein expression and resistance to cisplatin in a human germ cell tumor cell line.
    Koropatnick J, Kloth DM, Kadhim S, Chin JL, Cherian MG.
    J Pharmacol Exp Ther; 1995 Dec 01; 275(3):1681-7. PubMed ID: 8531144
    [Abstract] [Full Text] [Related]

  • 13. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells.
    Wang P, Branch DR, Bali M, Schultz GA, Goss PE, Jin T.
    Biochem J; 2003 Oct 01; 375(Pt 1):199-205. PubMed ID: 12841847
    [Abstract] [Full Text] [Related]

  • 14. Retinoic acid differentially regulates cancer cell proliferation via dose-dependent modulation of the mitogen-activated protein kinase pathway.
    Crowe DL, Kim R, Chandraratna RA.
    Mol Cancer Res; 2003 May 01; 1(7):532-40. PubMed ID: 12754300
    [Abstract] [Full Text] [Related]

  • 15. Direct reaction of H2O2 with sulfhydryl groups in HL-60 cells: zinc-metallothionein and other sites.
    Quesada AR, Byrnes RW, Krezoski SO, Petering DH.
    Arch Biochem Biophys; 1996 Oct 15; 334(2):241-50. PubMed ID: 8900398
    [Abstract] [Full Text] [Related]

  • 16. 13-cis retinoic acid and all-trans retinoic acid in the regulation of the proliferation and survival of human breast cancer cell line MCF-7.
    Czeczuga-Semeniuk E, Wolczyński S, Dziecioł J, Dabrowska M, Anchim T, Tomaszewska I.
    Cell Mol Biol Lett; 2001 Oct 15; 6(4):925-39. PubMed ID: 11753438
    [Abstract] [Full Text] [Related]

  • 17. Retinoic acid inhibition of human breast carcinoma proliferation is accompanied by inhibition of the synthesis of a Mr 39,000 protein.
    Fontana JA, Miranda D, Mezu AB.
    Cancer Res; 1990 Apr 01; 50(7):1977-82. PubMed ID: 2317786
    [Abstract] [Full Text] [Related]

  • 18. Synergistic antiproliferative effect of human recombinant interferons and retinoic acid in cultured breast cancer cells.
    Marth C, Daxenbichler G, Dapunt O.
    J Natl Cancer Inst; 1986 Dec 01; 77(6):1197-202. PubMed ID: 3099046
    [Abstract] [Full Text] [Related]

  • 19. Activation of human monocytes with lipopolysaccharide induces metallothionein expression and is diminished by zinc.
    Leibbrandt ME, Koropatnick J.
    Toxicol Appl Pharmacol; 1994 Jan 01; 124(1):72-81. PubMed ID: 8291064
    [Abstract] [Full Text] [Related]

  • 20. Retinoic acid causes cell growth arrest and an increase in p27 in F9 wild type but not in F9 retinoic acid receptor beta2 knockout cells.
    Li R, Faria TN, Boehm M, Nabel EG, Gudas LJ.
    Exp Cell Res; 2004 Mar 10; 294(1):290-300. PubMed ID: 14980522
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.